BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leonardi A, Di Stefano A, Vicari C, Motterle L, Brun P. Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis. Allergy 2011;66:1360-6. [PMID: 21545429 DOI: 10.1111/j.1398-9995.2011.02612.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Roy N, Levanon S, Asbell PA. Potential Biomarkers for Allergic Conjunctival Diseases. Eye Contact Lens 2020;46 Suppl 2:S109-21. [PMID: 32097185 DOI: 10.1097/ICL.0000000000000688] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chigbu DI, Coyne AM. Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. Clin Ophthalmol 2015;9:1215-25. [PMID: 26185412 DOI: 10.2147/OPTH.S63790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
3 Shoji J. Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases. Allergol Int 2020;69:496-504. [PMID: 32563624 DOI: 10.1016/j.alit.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Walter M, Kottke T, Stark H. The histamine H₄ receptor: targeting inflammatory disorders. Eur J Pharmacol 2011;668:1-5. [PMID: 21741967 DOI: 10.1016/j.ejphar.2011.06.029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
5 Gomes P, Slocum C, Smith LM, Abelson MB. Challenges faced in clinical trials for chronic allergic conjunctivitis. Expert Review of Ophthalmology 2015;10:509-18. [DOI: 10.1586/17469899.2015.1081563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Leonardi A, Palmigiano A, Mazzola EA, Messina A, Milazzo EMS, Bortolotti M, Garozzo D. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics. Allergy 2014;69:254-60. [DOI: 10.1111/all.12331] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
7 Zong RR, Zhu FF, Han W, Wang YX, Wang GL, Wang YZ, Mao YB, Guan TJ, Liu ZG, Xue YH, Li C. Tear dynamics testing and quantitative proteomics analysis in patients with chronic renal failure. J Proteomics 2021;248:104351. [PMID: 34411762 DOI: 10.1016/j.jprot.2021.104351] [Reference Citation Analysis]
8 Kiss R, Keserű GM. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 2012;22:205-21. [PMID: 22385042 DOI: 10.1517/13543776.2012.665447] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
9 Meng XT, Shi YY, Zhang H, Zhou HY. The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis. J Ophthalmol 2020;2020:6917185. [PMID: 32566265 DOI: 10.1155/2020/6917185] [Reference Citation Analysis]
10 Pattnaik L, Acharya L. A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sciences 2015;128:47-54. [DOI: 10.1016/j.lfs.2015.01.040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
11 Singh RB, Liu L, Anchouche S, Yung A, Mittal SK, Blanco T, Dohlman TH, Yin J, Dana R. Ocular redness - I: Etiology, pathogenesis, and assessment of conjunctival hyperemia. Ocul Surf 2021;21:134-44. [PMID: 34010701 DOI: 10.1016/j.jtos.2021.05.003] [Reference Citation Analysis]
12 Leonardi A. Allergy and allergic mediators in tears. Experimental Eye Research 2013;117:106-17. [DOI: 10.1016/j.exer.2013.07.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
13 Park Y, Ellis D, Mueller B, Stankowska D, Yorio T. Principles of Ocular Pharmacology. Handb Exp Pharmacol 2017;242:3-30. [PMID: 27730396 DOI: 10.1007/164_2016_25] [Reference Citation Analysis]
14 Willcox MDP. Is There a Role for Inflammation in Contact Lens Discomfort? Eye & Contact Lens: Science & Clinical Practice 2017;43:5-16. [DOI: 10.1097/icl.0000000000000343] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 4.6] [Reference Citation Analysis]
15 Sacchetti M, Bruscolini A, Abicca I, Nebbioso M, La Cava M, Bonini S, Lambiase A. Current and emerging treatment options for vernal keratoconjunctivitis. Expert Opinion on Orphan Drugs 2017;5:343-53. [DOI: 10.1080/21678707.2017.1300524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Inada N, Shoji J, Shiraki Y, Aso H, Yamagami S. Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases. Allergol Int 2017;66:586-93. [PMID: 28391980 DOI: 10.1016/j.alit.2017.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hong SM, Park IH, Um JY, Shin JM, Lee HM. Stimulatory effects of histamine on migration of nasal fibroblasts. Int Forum Allergy Rhinol 2015;5:923-8. [PMID: 26097205 DOI: 10.1002/alr.21555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
18 Abelson MB, Shetty S, Korchak M, Butrus SI, Smith LM. Advances in pharmacotherapy for allergic conjunctivitis. Expert Opin Pharmacother 2015;16:1219-31. [PMID: 25943976 DOI: 10.1517/14656566.2015.1040760] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
19 Irkec MT, Bozkurt B. Molecular immunology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol 2012;12:534-9. [PMID: 22885886 DOI: 10.1097/ACI.0b013e328357a21b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Modena BD, Dazy K, White AA. Emerging concepts: mast cell involvement in allergic diseases. Transl Res 2016;174:98-121. [PMID: 26976119 DOI: 10.1016/j.trsl.2016.02.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
21 Sgambellone S, Lucarini L, Lanzi C, Masini E. Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina Neuroprotection. Biomolecules 2021;11:1186. [PMID: 34439851 DOI: 10.3390/biom11081186] [Reference Citation Analysis]
22 Tamhane M, Cabrera-Ghayouri S, Abelian G, Viswanath V. Review of Biomarkers in Ocular Matrices: Challenges and Opportunities. Pharm Res 2019;36:40. [PMID: 30673862 DOI: 10.1007/s11095-019-2569-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
23 Sacchetti M, Plateroti R, Bruscolini A, Giustolisi R, Marenco M. Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms. Life (Basel) 2021;11:1012. [PMID: 34685384 DOI: 10.3390/life11101012] [Reference Citation Analysis]
24 Li D, Carozza RB, Shatos MA, Hodges RR, Dartt DA. Effect of histamine on Ca(2+)-dependent signaling pathways in rat conjunctival goblet cells. Invest Ophthalmol Vis Sci 2012;53:6928-38. [PMID: 22956601 DOI: 10.1167/iovs.12-10163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]